Related Experiment Video
Updated: May 7, 2025
Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
Targeting mitochondrial transfer: a new horizon in cardiovascular disease treatment
Baile Zuo1, Xiaoyan Li2,3, Dawei Xu2
1Molecular Immunology and Immunotherapy Laboratory, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan, China.
Insights
Mitochondrial transfer plays a key role in cardiovascular diseases (CVDs) and obesity. Understanding mitochondrial transfer mechanisms offers new therapeutic strategies for treating CVDs.
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Obesity Research
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death globally, with obesity being a significant risk factor.
- Mitochondria are crucial for cardiovascular function, and their transfer is implicated in CVD pathogenesis and obesity.
- Mitochondrial dysfunction impacts energy metabolism and signal transduction in the cardiovascular system.
Purpose of the Study:
- To comprehensively review the role of mitochondrial transfer in cardiovascular health and disease.
- To explore the molecular mechanisms governing mitochondrial transfer.
- To discuss the therapeutic potential and challenges of modulating mitochondrial transfer for CVD treatment.
Main Methods:
- Literature review of existing research on mitochondrial transfer, CVDs, and obesity.
- Analysis of the functions of mitochondria in cardiovascular systems.
- Examination of molecular pathways involved in mitochondrial transfer.
Main Results:
- Disruptions in mitochondrial transfer are linked to myocardial infarction, cardiomyopathies, and hypertension.
- Mitochondrial transfer influences energy metabolism and signal transduction, impacting cardiovascular health.
- Mitochondrial transfer holds therapeutic promise for various cardiovascular conditions.
Conclusions:
- Mitochondrial transfer is a critical factor in cardiovascular disease development and progression.
- Targeted modulation of mitochondrial transfer presents a promising therapeutic avenue for CVDs.
- Further research into mitochondrial transfer mechanisms is essential for developing effective CVD treatments.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of mortality among individuals with noncommunicable diseases worldwide. Obesity is associated with an increased risk of developing cardiovascular disease (CVD). Mitochondria are integral to the cardiovascular system, and it has been reported that mitochondrial transfer is associated with the pathogenesis of multiple CVDs and obesity. This review offers a comprehensive examination of the relevance of mitochondrial transfer to cardiovascular health and disease, emphasizing the critical functions of mitochondria in energy metabolism and signal transduction within the cardiovascular system. This highlights how disruptions in mitochondrial transfer contribute to various CVDs, such as myocardial infarction, cardiomyopathies, and hypertension. Additionally, we provide an overview of the molecular mechanisms governing mitochondrial transfer and its potential implications for CVD treatment. This finding underscores the therapeutic potential of mitochondrial transfer and addresses the various mechanisms and challenges in its implementation. By delving into mitochondrial transfer and its targeted modulation, this review aims to advance our understanding of cardiovascular disease treatment, presenting new insights and potential therapeutic strategies in this evolving field.
